InSite Vision has secured the new patent for its DuraSite 2 next-generation enhanced drug delivery system from the United States Patent and Trademark Office (USPTO). DuraSite 2's ability to significantly improve drug retention and ...
Tags: Insite Vision, Ophthalmic Drug
Facing a slight downturn in the overall market, Medical technology provider Carl Zeiss Meditec AG raised its revenue by 2.9 percent to EUR 649 million (previous year: EUR 630.8 million) in the first nine months of financial year 2011/2012. ...
Tags: Medical technology, Carl Zeiss
Valeant Pharmaceuticals International has closed the acquisition of Bausch + Lomb Holdings, a US-based manufacturer of eye health products, for $8.7bn. Bausch + Lomb Holdings has a broad portfolio of eye health products, including OTC ...
Tags: Valeant Pharmaceuticals
Novartis has received an approval from the European Commission for its Lucentis (ranibizumab) to treat patients with visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV). Lucentis is a ...
Specialty pharmaceutical company Sun Pharmaceutical Industries has obtained final USFDA approval for the abbreviated new drug application of generic Depo-Testosterone Injection, Testosterone Cypionate Injection USP, 100mg/ml and 200mg/ml. ...
US-based specialty pharmaceutical company, pSivida has entered into a funded technology evaluation agreement with an undisclosed pharmaceutical company. The deal will assess the Durasert technology, pSivida's core technology system, for ...
Dermatology products developer Valeant Pharmaceuticals International has entered into a definitive agreement to acquire contact lenses developer Bausch + Lomb Holdings for a cash consideration of $8.7bn, as part of its strategy to enhance ...
Liquidia Technologies is planning to set up a new ophthalmology-focused company to manufacture products that address the unmet needs, growth therapeutic areas and to maximize the return for its investors. The proposal follows the success ...
Tags: Liquidia, Ophthalmology Company
Neuroscience biotech company Cerecor has acquired exclusive, worldwide rights to develop and commercialize MK-0657 from Merck, referred to MSD outside the US and Canada. The small molecule NMDA receptor subunit 2B antagonist MK-0657 will ...
Tags: Cerecor, Global Development Rights, MK-0657
The US Patent and Trademark Office (USPTO) has granted a patent to Biolase's non-contact handpiece designed for cutting both hard and soft tissue. The non-contact laser handpiece, which the company claims, is the only one that is ...
Iridex, a developer for ophthalmology and otolaryngology market, has entered into a global distribution and supply agreement with Peregrine Surgical, a Pennsylvania-based privately held company. Under the terms of the agreement, Iridex ...
Tags: Iridex Inks, Labeled Products, Medicine
Merck, referred to as MSD outside the US and Canada, and Luminex have signed a deal to develop a companion diagnostic device to support patient selection for the clinical development program of investigational drug MK-8931 to treat ...
Tags: companion diagnostic device, drug, Merck
CHICAGO, IL, February 19, 2013 /24-7PressRelease/ -- Cameleon Software, the global leader in product design, sales configuration, quotes, and proposals software, today announced its net income for fiscal 2012, as approved by its Board of ...
Tags: Cameleon Software, Software, Revenue
Got a relative with an age-related eye problem? If so, an iPad or other tablet with a backlit display might make a great gift. The contrast between background and text on those devices makes reading easier for people with macular ...
Tags: iPad, backlit display, tablet, Retina display
German glass and plastic packaging products manufacturer Gerresheimer is all set to exhibit its entire portfolio of products for the pharma and healthcare industries on 13-14 February 2013 at Pharmapack, Paris. The company's portfolio ...
Tags: Healthcare Packaging, Packaging, packaging products, foil seal